STERIS (NYSE:STE) Stock Price & Quote Analysis

STE fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	3/6
Past Performance	0/6
Financial Health	3/6
Dividends	3/6

STE Stock Overview

STERIS plc provides infection prevention and other procedural products and services worldwide.

Rewards

Earnings are forecast to grow 43.11% per year

Risk Analysis

Has a high level of debt

Significant insider selling over the past 3 months

STERIS plc Competitors

Hologic

NasdaqGS:HOLX

US$18.4b

Insulet

NasdaqGS:PODD

US$21.1b

Abiomed

NasdaqGS:ABMD

US$17.2b

Baxter International

NYSE:BAX

US$26.5b

Price History & Performance

Summary of all time highs, changes and price drops for STERIS
Historical stock prices
Current Share Price	US$190.28
52 Week High	US$255.93
52 Week Low	US$159.21
Beta	0.82
1 Month Change	16.31%
3 Month Change	-9.52%
1 Year Change	-18.11%
3 Year Change	23.83%
5 Year Change	117.29%
Change since IPO	9,125.70%

Steris declares $0.47 dividend

Nov 02

Recent updates

The Case For STERIS plc (NYSE:STE): Could It Be A Nice Addition To Your Dividend Portfolio?

Mar 18

Is Weakness In STERIS plc (NYSE:STE) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 03

Why You Might Be Interested In STERIS plc (NYSE:STE) For Its Upcoming Dividend

Feb 18

Did Business Growth Power STERIS' (NYSE:STE) Share Price Gain of 188%?

Feb 15

STERIS plc (NYSE:STE) Insiders Have Been Selling

Jan 26

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Safely

Jan 12

Do STERIS's (NYSE:STE) Earnings Warrant Your Attention?

Dec 28

STERIS plc (NYSE:STE) Has Got What It Takes To Be An Attractive Dividend Stock

Dec 15

Are Robust Financials Driving The Recent Rally In STERIS plc's (NYSE:STE) Stock?

Nov 30

Shareholder Returns

	STE	US Medical Equipment	US Market
7D	-1.1%	-1.1%	-2.8%
1Y	-18.1%	-20.9%	-19.6%

Return vs Industry: STE exceeded the US Medical Equipment industry which returned -22.9% over the past year.

Return vs Market: STE exceeded the US Market which returned -21.2% over the past year.

Price Volatility

Is STE's price volatile compared to industry and market?
STE volatility
STE Average Weekly Movement	5.2%
Medical Equipment Industry Average Movement	8.9%
Market Average Movement	7.4%
10% most volatile stocks in US Market	15.5%
10% least volatile stocks in US Market	3.3%

Stable Share Price: STE is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: STE's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1985	16,000	Dan Carestio	https://www.steris.com

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

STERIS plc Fundamentals Summary

How do STERIS's earnings and revenue compare to its market cap?
STE fundamental statistics
Market Cap	US$18.99b
Earnings (TTM)	-US$8.14m
Revenue (TTM)	US$4.78b

4.0x

P/S Ratio

-2,334x

P/E Ratio

Is STE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
STE income statement (TTM)
Revenue	US$4.78b
Cost of Revenue	US$2.70b
Gross Profit	US$2.08b
Other Expenses	US$2.09b
Earnings	-US$8.14m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-0.082
Gross Margin	43.49%
Net Profit Margin	-0.17%
Debt/Equity Ratio	52.0%

How did STE perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

-2,163%

Payout Ratio

STE Stock Overview

Rewards

Risk Analysis

STERIS plc Competitors

NasdaqGS:HOLX

US$18.4b

NasdaqGS:PODD

US$21.1b

NasdaqGS:ABMD

US$17.2b

NYSE:BAX

US$26.5b

Price History & Performance

Recent News & Updates

Insider recently sold US$308k worth of stock

Upcoming dividend of US$0.47 per share

STERIS plc Revises Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: Revenues miss analyst expectations

STERIS plc Declares Interim Dividend, Payable on December 16, 2022

Steris declares $0.47 dividend

Recent updates

Insider recently sold US$308k worth of stock

Upcoming dividend of US$0.47 per share

STERIS plc Revises Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: Revenues miss analyst expectations

STERIS plc Declares Interim Dividend, Payable on December 16, 2022

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Price target decreased to US$230

STERIS plc to Report Q2, 2023 Results on Nov 09, 2022

Upcoming dividend of US$0.47 per share

STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

First quarter 2023 earnings: EPS and revenues miss analyst expectations

STERIS plc Provides Revenue Guidance for Fiscal 2023

Steris plc Declares Quarterly Interim Dividend, Payable on September 23, 2022

STERIS plc to Report Q1, 2023 Results on Aug 02, 2022

Is STERIS (NYSE:STE) A Risky Investment?

STERIS plc(NYSE:STE) dropped from Russell 1000 Growth-Defensive Index

Senior VP notifies of intention to sell stock

Independent Director exercised options to buy US$733k worth of stock.

STERIS plc, Annual General Meeting, Jul 28, 2022

Upcoming dividend of US$0.43 per share

Full year 2022 earnings: EPS misses analyst expectations

STERIS plc Provides Earnings Guidance for Fiscal 2023

Steris plc Declares Quarterly Interim Dividend, Payable on June 28, 2022

Senior VP notifies of intention to sell stock

STERIS plc to Report Q4, 2022 Results on May 11, 2022

Senior VP exercised options and sold US$1.5m worth of stock

Senior VP & CFO notifies of intention to sell stock

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Chief Accounting Officer notifies of intention to sell stock

Upcoming dividend of US$0.43 per share

Independent Director notifies of intention to sell stock

Third quarter 2022 earnings: EPS exceeds analyst expectations

STERIS plc Raises Earnings Guidance for the Fiscal Year 2022

STERIS plc Declares Quarterly Interim Dividend, Payable March 24, 2022

Senior VP & CFO notifies of intention to sell stock

Is STERIS (NYSE:STE) A Risky Investment?

Insider recently sold US$454k worth of stock

Upcoming dividend of US$0.43 per share

Second quarter 2022 earnings released: EPS US$0.70 (vs US$1.24 in 2Q 2021)

STERIS (NYSE:STE) Is Increasing Its Dividend To US$0.43

Senior VP & CFO exercised options and sold US$3.3m worth of stock

VP & Corporate Treasurer exercised options and sold US$162k worth of stock

STERIS' (NYSE:STE) Dividend Will Be Increased To US$0.43

Upcoming dividend of US$0.43 per share

Insider recently sold US$2.4m worth of stock

Consensus forecasts updated

CEO Emeritus & Senior Advisor notifies of intention to sell stock

STERIS (NYSE:STE) Is Increasing Its Dividend To US$0.43

STERIS plc Provides Earnings Guidance for the Year 2022

First quarter 2022 earnings released: US$0.24 loss per share (vs US$1.04 profit in 1Q 2021)

Independent Director David Lewis has left the company

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

Independent Director exercised options to buy US$335k worth of stock.

STERIS plc (NYSE:STE) completed the acquisition of Cantel Medical Corp. (NYSE:CMD) from Charles M. Diker, Mark N. Diker, Diker Management LLC, Champlain Investment Partners, LLC, Brown Capital Management, LLC and others.

Independent Director notifies of intention to sell stock

Consensus forecasts updated

Full year 2021 earnings released: EPS US$4.66 (vs US$4.81 in FY 2020)

STERIS plc Provides Earnings Guidance for the Fiscal Year Ending March 31, 2022